Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HULTA PHARMA Fact Sheet  (HTPH)



Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research


Here is the latest financial fact sheet of HULTA PHARMA. For more details, see the HULTA PHARMA quarterly results and HULTA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

HULTA PHARMA Price History

Price Rs 7.0
Mkt Cap Rs m 52
Vol '000 0.0
P/E X -14.7
P/CF X -16.4
EPS (TTM) Rs -0.5
1 Day % 0.0
No. of shares m 7.45
1 Week % 0.9
1 Month % -22.2
1 Year % 66.4
52 week H/L Rs 11.2/3.8
As on Apr 23, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

HULTA PHARMA Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
HULTA PHARMA EQUITY SHARE DATA
High Rs788910 
Low Rs44433 
Sales per share (Unadj.) Rs00.2000 
Earnings per share (Unadj.) Rs-0.2-0.1-0.3-0.4-0.4 
Diluted earnings per shareRs-0.2-0.1-0.3-0.4-0.4 
Cash flow per share (Unadj.) Rs-0.2-0.1-0.3-0.4-0.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs0.1-0.1-0.3-0.8-1.2 
Adj. book value per shareRs0.1-0.1-0.3-0.8-1.2 
Shares outstanding (eoy) m7.457.457.457.457.45 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x037.9000 
Avg P/E ratio x-36.3-41.9-20.2-13.5-15.7 
P/CF ratio (eoy) x-36.5-42.0-20.2-13.5-15.7 
Price / Book Value ratio x62.6-115.1-17.1-7.7-5.6 
Dividend payout %00000 
Avg Mkt Cap Rs m4143434450 
No. of employees `000NANANANANA 
Total wages/salary Rs m01111 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
HULTA PHARMA INCOME DATA
Net Sales Rs m01000 
Other income Rs m00100 
Total revenues Rs m01100 
Gross profit Rs m-1-1-3-3-3 
Depreciation Rs m00000 
Interest Rs m00001 
Profit before tax Rs m-1-1-2-3-3 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00000 
Profit after tax Rs m-1-1-2-3-3 
Gross profit margin %0-90.6000 
Effective tax rate %00000 
Net profit margin %0-91.1000 
HULTA PHARMA BALANCE SHEET DATA
Current assets Rs m00000 
Current liabilities Rs m00000 
Net working cap to sales %0-5.4000 
Current ratio x3.50.80.44.33.6 
Inventory Days Days0107000 
Debtors Days Days00000 
Net fixed assets Rs m00000 
Share capital Rs m7575757575 
"Free" reserves Rs m-74-75-77-80-83 
Net worth Rs m10-2-6-9 
Long term debt Rs m013610 
Total assets Rs m11011 
Interest coverage x00-22.4-9.2-4.8 
Debt to equity ratio x0-1.7-1.1-1.1-1.1 
Sales to assets ratio x01.9000 
Return on assets %-144.5-175.4-562.4-499.3-361.5 
Return on equity %-173.0273.284.956.735.6 
Return on capital %-172.9-383.3-698.1-555.8-425.6 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
HULTA PHARMA CASH FLOW
From Operations Rs m -1 -1 -2 -3 -3 
From Investments Rs m 2 0 0 0 0 
From Financial Activity Rs m 0 1 2 4 3 
Net Cashflow Rs m 0 -0 -0 0 -0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 56.3%
Institution 1.1%
Non-Institution 42.6%
Total 100.0%
Free Float 43.7%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off Old No. 249 New No. 339 Safi House, 2nd Floor Mount Road, Teynampet, Chennai - 600006
E-mail epsomproperties@gmail.com Web www.epsom.in
Tel 044- 66805560 Fax
Sector CONSTRUCTION Group Epsom Properties - MNC
Tr Agent Cameo Corporate Services Ltd, Subramanian Buildings No 1, Club House Road
CHM: Mohan Swami COMP SEC: Harshita Sitlani YEAR OF INC: 1987 BSE CODE: 531155 FV (Rs): 10 DIV YIELD (%): -

More Construction Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare HULTA PHARMA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    




Today's Market

Tata Consumer Q4 Results & Interim Dividend | M&M Finance Delays Q4 Results | Top Buzzing Stocks Today Tata Consumer Q4 Results & Interim Dividend | M&M Finance Delays Q4 Results | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended the higher.